US83422E2046
US83422E2046
Solid Biosciences Inc.
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 736.64M EUR | 1.05B EUR | 708.44M EUR | 445.38M EUR |
Enterprise Value | 373.75M EUR | 910.96M EUR | 432.01M EUR | 406.64M EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -4.03x | -- | -- | -- |
Price to Sales | -- | -- | -- | -- |
Price to Book | 1.93x | 2.81x | 1.89x | 2.47x |
EV/Revenue | -- | -- | -- | -- |
EV/EBITDA | -1.78x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -16.05% | -17.88% | -24.4% | -28.17% |